Anti-Dicer antibody [13D6] - ChIP Grade (ab14601)
Key features and details
- Mouse monoclonal [13D6] to Dicer - ChIP Grade
- Suitable for: WB, ChIP, Flow Cyt
- Knockout validated
- Reacts with: Mouse, Human
- Isotype: IgG2a
Overview
-
Product name
Anti-Dicer antibody [13D6] - ChIP Grade
See all Dicer primary antibodies -
Description
Mouse monoclonal [13D6] to Dicer - ChIP Grade -
Host species
Mouse -
Specificity
We do not guarantee its use in WB with mouse lysates. -
Tested applications
Suitable for: WB, ChIP, Flow Cytmore details -
Species reactivity
Reacts with: Mouse, Human
Does not react with: Caenorhabditis elegans -
Immunogen
Synthetic peptide corresponding to Human Dicer.
-
Positive control
- WB: 10ng of recombinant dicer (using ECL or ECL Plus) in under one minute of exposure to film. ICC: Human Fibroblasts
-
General notes
To our knowledge the localization of Dicer remains to be fully determined and it appears that its localization can be nuclear and/or cytoplasmic. Please see reference Meltzer, 2005 for a reference to a cytoplasmic localisation (figure 1 of paper), as supported with the staining seen in the image on this datasheet.
Please note this antibody gave negative results in WB with mouse fibroblast cell line lysates. We do not guarantee its use in WB with mouse lysates.The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle. -
Storage buffer
Preservative: 0.02% Sodium azide
Constituent: HEPES buffered saline -
Concentration information loading...
-
Purity
Ammonium Sulphate Precipitation -
Clonality
Monoclonal -
Clone number
13D6 -
Isotype
IgG2a -
Research areas
Associated products
-
ChIP Related Products
-
Compatible Secondaries
-
Conjugation kits
-
Isotype control
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab14601 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB | (9) |
1/100 - 1/2000.
Please note this antibody gave negative results in WB with mouse fibroblast cell line lysates. We do not guarantee its use in WB with mouse lysates. |
ChIP |
Use at an assay dependent concentration.
|
|
Flow Cyt |
Use 0.1µg for 106 cells.
ab170191 - Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody. |
Notes |
---|
WB
1/100 - 1/2000. Please note this antibody gave negative results in WB with mouse fibroblast cell line lysates. We do not guarantee its use in WB with mouse lysates. |
ChIP
Use at an assay dependent concentration. |
Flow Cyt
Use 0.1µg for 106 cells. ab170191 - Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody. |
Target
-
Function
Double-stranded RNA (dsRNA) endoribonuclease playing a central role in short dsRNA-mediated post-transcriptional gene silencing. Cleaves naturally occurring long dsRNAs and short hairpin pre-microRNAs (miRNA) into fragments of twenty-one to twenty-three nucleotides with 3' overhang of two nucleotides, producing respectively short interfering RNAs (siRNA) and mature microRNAs. SiRNAs and miRNAs serve as guide to direct the RNA-induced silencing complex (RISC) to complementary RNAs to degrade them or prevent their translation. Gene silencing mediated by siRNAs, also called RNA interference, controls the elimination of transcripts from mobile and repetitive DNA elements of the genome but also the degradation of exogenous RNA of viral origin for instance. The miRNA pathway on the other side is a mean to specifically regulate the expression of target genes. -
Involvement in disease
Pleuropulmonary blastoma
Goiter multinodular 1, with or without Sertoli-Leydig cell tumors
Rhabdomyosarcoma, embryonal, 2
DICER1 mutations have been found in uterine cervix embryonal rhabdomyosarcoma, primitive neuroectodermal tumor, Wilms tumor, pulmonary sequestration and juvenile intestinal polyp (PubMed:21882293). Somatic missense mutations affecting the RNase IIIb domain of DICER1 are common in non-epithelial ovarian tumors. These mutations do not abolish DICER1 function but alter it in specific cell types, a novel mechanism through which perturbation of microRNA processing may be oncogenic (PubMed:22187960). -
Sequence similarities
Belongs to the helicase family. Dicer subfamily.
Contains 1 Dicer dsRNA-binding fold domain.
Contains 1 DRBM (double-stranded RNA-binding) domain.
Contains 1 helicase ATP-binding domain.
Contains 1 helicase C-terminal domain.
Contains 1 PAZ domain.
Contains 2 RNase III domains. -
Cellular localization
Cytoplasm. - Information by UniProt
-
Database links
- Entrez Gene: 23405 Human
- Entrez Gene: 192119 Mouse
- Omim: 606241 Human
- SwissProt: Q9UPY3 Human
- SwissProt: Q8R418 Mouse
- Unigene: 738957 Human
- Unigene: 87889 Human
- Unigene: 21135 Mouse
-
Alternative names
- DCR antibody
- DCR1 antibody
- Dicer 1 ribonuclease III antibody
see all
Images
-
Lane 1: Wild-type HAP1 cell lysate (20 µg)
Lane 2: Dicer knockout HAP1 cell lysate (20 µg)Lanes 1 and 2: Merged signal (red and green). Green - ab14601 observed at 240 kDa. Red - loading control, ab181602, observed at 37 kDa.
ab14601 was shown to specifically react with Dicer in wild-type HAP1 cells. No band was observed when Dicer knockout samples were used. Wild-type and Dicer knockout samples were subjected to SDS-PAGE. ab14601 and ab181602 (loading control to GAPDH) were diluted 1/1000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) and Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) secondary antibodies at 1/10,000 dilution for 1hr at room temperature before imaging. -
All lanes : Anti-Dicer antibody [13D6] - ChIP Grade (ab14601) at 1/2000 dilution (incubated overnight at 4°C.)
Lane 1 : NIH 3T3
Lane 2 : A549
Lane 3 : HepG2
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat anti-Mouse Green at 1/10000 dilutionThis blot was produced using a 3-8% Tris Acetate gel under the TA buffer system. The gel was run at 150V for 60 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour before being incubated with ab14601 overnight at 4°C. Antibody binding was detected using IR-labelled goat anti-mouse Ab at a 1:10,000 dilution for 1hr at room temperature and then imaged using the Licor Odyssey CLx.
-
Overlay histogram showing HEK293 cells stained with ab14601 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab14601, 0.1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.
-
HepG2 cell lysate at 20 µg
Developed using the ECL technique.
Performed under reducing conditions.
Additional bands at: 100 kDa (possible non-specific binding), 60 kDa (possible non-specific binding) -
ChIP - Anti-Dicer antibody [13D6] - ChIP Grade (ab14601)This image is courtesy of Elliot Epner MD PhD, Oregon Health and Science University, Portland
ChIP analysis of Dicer protein binding at chicken ß-globin regulatory elements. Chromatin from human erythroleukemia (K562) cells containing chicken chromosomes with normal (FRK2) or mutant (HS1-K) ß-globin loci and chicken DT40 cells was immunprecipitated with antibodies to Dicer (ab14601). PCR analysis of immunoprecipitated chromatin was carried out using primers to the chicken ß-globin regulatory elements. Mouse IgG served as control. 10% of input DNA was utilized.
-
Western blot - Anti-Dicer antibody [13D6] - ChIP Grade (ab14601)This image is courtesy of Jing Huang and Elliot Epner Oregon Health and Science UniversityAll lanes : Anti-Dicer antibody [13D6] - ChIP Grade (ab14601) at 2.5 µg/ml
Lane 1 : human B cell lymphoma lysate
Lane 2 : human B cell lymphoma lysate infected with control shRNA retrovirus
Lane 3 : human B cell lymphoma lysate infected with Dicer knockdown shRNA virus
Lysates/proteins at 2.5 µg/ml per lane.
Observed band size: 225 kDa why is the actual band size different from the predicted?
Protocols
Datasheets and documents
-
SDS download
-
Datasheet download
References (149)
ab14601 has been referenced in 149 publications.
- Tseng CF et al. Transcriptional suppression of Dicer by HOXB-AS3/EZH2 complex dictates sorafenib resistance and cancer stemness. Cancer Sci 113:1601-1612 (2022). PubMed: 35253323
- Meseguer S & Rubio MP mt tRFs, New Players in MELAS Disease. Front Physiol 13:800171 (2022). PubMed: 35273517
- Ahn S et al. Tumor-derived miR-130b-3p induces cancer-associated fibroblast activation by targeting SPIN90 in luminal A breast cancer. Oncogenesis 11:47 (2022). PubMed: 35948548
- Hsu TW et al. Dicer-mediated miR-200b expression contributes to cell migratory/invasive abilities and cancer stem cells properties of breast cancer cells. Aging (Albany NY) 14:6520-6536 (2022). PubMed: 35951366
- Li Z et al. Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer. Oxid Med Cell Longev 2022:2896049 (2022). PubMed: 36062197